On this programme we speak with a local district councillor to discuss the impact of the upcoming Kai Tak Hospital - Hong Kong's largest medical facility - and its role as a vital public healthcare hub for the community.
Then, we learn about a new technique introduced at Queen Mary Hospital that can minimise wounds caused by surgery on prostate cancer patients.
After the break, we're joined by members of a research team from the Chinese University of Hong Kong and its biotech spin-off company to find out how their their experimental peptide drug won US FDA approval to treat Huntington's disease.
And to wrap up the show, we look back at Hong Kong, China's success so far at the Asian Games, which concluded on Sunday in Nagoya.
9:05am-9:24am: Kai Tak Hospital opening
Speaker:
Rizwan Ullah, Kowloon City District Councillor
9:24am-9:30am: New surgical method for prostate cancer
Speaker:
Wong Hoi-lung, Associate Consultant at the Urology Division, Queen Mary Hospital
9:32am-9:45am: CUHK develops novel drug for Huntington's disease
Speakers:
Edwin Chan, Director of the School of Life Sciences at the Chinese University of Hong Kong and Co-Founder of Rare Power Limited
Maggie Leung, Co-Founder and Chief Technological Officer of Rare Power Limited
9:45am-10:00am: Asian Games wrap-up
Speaker:
Cheng King-leung, Chairman of the Elite Sports Committee